Reputation
Some parts of society continue to challenge the pharmaceuticals industry, which is under the close scrutiny of the public, the media and other stakeholders. Rising expectations are especially noteworthy in the areas of improving access to medicines for the underprivileged, both in our established markets and in less-developed nations; business conduct in our supply chain; fair marketing practices; bio-ethical challenges; working conditions; human rights; and animal rights. Although we seek to manage these risks through various proactive measures, there can be no assurance that in the future such risks will not have a materially adverse effect on our financial condition or results of operations.
